Therapeutic potential of TGF-β-induced CD4+ Foxp3 + regulatory T cells in autoimmune diseases

Xiaohui Zhou, Ning Kong, Hejian Zou, David Brand, Xianpei Li, Zhongmin Liu, Song Guo Zheng

Research output: Contribution to journalReview article

47 Citations (Scopus)

Abstract

Foxp3+ T regulatory cell (Treg) subsets play a crucial role in the maintenance of immune homeostasis against self-antigens. The lack or dysfunction of these cells contributes to the pathogenesis and development of many autoimmune diseases. Therefore, manipulation of these cells may provide a novel therapeutic approach to treat autoimmune diseases. In this review, we provide current opinions concerning the classification, developmental, and functional characterization of Treg subsets. Particular emphasis will be focused on the therapeutic role of TGF-β-induced CD4M+ Foxp3 + cells (iTregs) in established autoimmune disease. Moreover, the similarity and diversity of iTregs and naturally occurring, thymus-derived CD4+ CD25+ Foxp3+ regulatory T cells (nTregs) will be discussed, including the finding that the pro-inflammatory cytokine IL-6 can convert nTregs to IL-17-producing cells, whereas iTregs induced by TGF-β are resistant to the effects of this cytokine. Understanding these aspects may help to determine how Tregs can be used in the treatment of autoimmune diseases.

Original languageEnglish (US)
Pages (from-to)43-50
Number of pages8
JournalAutoimmunity
Volume44
Issue number1
DOIs
StatePublished - Feb 1 2011

Fingerprint

Regulatory T-Lymphocytes
Autoimmune Diseases
T-Lymphocyte Subsets
Cytokines
Interleukin-17
Autoantigens
Therapeutics
Thymus Gland
Interleukin-6
Homeostasis
Maintenance

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Therapeutic potential of TGF-β-induced CD4+ Foxp3 + regulatory T cells in autoimmune diseases. / Zhou, Xiaohui; Kong, Ning; Zou, Hejian; Brand, David; Li, Xianpei; Liu, Zhongmin; Zheng, Song Guo.

In: Autoimmunity, Vol. 44, No. 1, 01.02.2011, p. 43-50.

Research output: Contribution to journalReview article

Zhou, Xiaohui ; Kong, Ning ; Zou, Hejian ; Brand, David ; Li, Xianpei ; Liu, Zhongmin ; Zheng, Song Guo. / Therapeutic potential of TGF-β-induced CD4+ Foxp3 + regulatory T cells in autoimmune diseases. In: Autoimmunity. 2011 ; Vol. 44, No. 1. pp. 43-50.
@article{28a4cad1938b49a9aa9b946c2efb20fe,
title = "Therapeutic potential of TGF-β-induced CD4+ Foxp3 + regulatory T cells in autoimmune diseases",
abstract = "Foxp3+ T regulatory cell (Treg) subsets play a crucial role in the maintenance of immune homeostasis against self-antigens. The lack or dysfunction of these cells contributes to the pathogenesis and development of many autoimmune diseases. Therefore, manipulation of these cells may provide a novel therapeutic approach to treat autoimmune diseases. In this review, we provide current opinions concerning the classification, developmental, and functional characterization of Treg subsets. Particular emphasis will be focused on the therapeutic role of TGF-β-induced CD4M+ Foxp3 + cells (iTregs) in established autoimmune disease. Moreover, the similarity and diversity of iTregs and naturally occurring, thymus-derived CD4+ CD25+ Foxp3+ regulatory T cells (nTregs) will be discussed, including the finding that the pro-inflammatory cytokine IL-6 can convert nTregs to IL-17-producing cells, whereas iTregs induced by TGF-β are resistant to the effects of this cytokine. Understanding these aspects may help to determine how Tregs can be used in the treatment of autoimmune diseases.",
author = "Xiaohui Zhou and Ning Kong and Hejian Zou and David Brand and Xianpei Li and Zhongmin Liu and Zheng, {Song Guo}",
year = "2011",
month = "2",
day = "1",
doi = "10.3109/08916931003782163",
language = "English (US)",
volume = "44",
pages = "43--50",
journal = "Autoimmunity",
issn = "0891-6934",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Therapeutic potential of TGF-β-induced CD4+ Foxp3 + regulatory T cells in autoimmune diseases

AU - Zhou, Xiaohui

AU - Kong, Ning

AU - Zou, Hejian

AU - Brand, David

AU - Li, Xianpei

AU - Liu, Zhongmin

AU - Zheng, Song Guo

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Foxp3+ T regulatory cell (Treg) subsets play a crucial role in the maintenance of immune homeostasis against self-antigens. The lack or dysfunction of these cells contributes to the pathogenesis and development of many autoimmune diseases. Therefore, manipulation of these cells may provide a novel therapeutic approach to treat autoimmune diseases. In this review, we provide current opinions concerning the classification, developmental, and functional characterization of Treg subsets. Particular emphasis will be focused on the therapeutic role of TGF-β-induced CD4M+ Foxp3 + cells (iTregs) in established autoimmune disease. Moreover, the similarity and diversity of iTregs and naturally occurring, thymus-derived CD4+ CD25+ Foxp3+ regulatory T cells (nTregs) will be discussed, including the finding that the pro-inflammatory cytokine IL-6 can convert nTregs to IL-17-producing cells, whereas iTregs induced by TGF-β are resistant to the effects of this cytokine. Understanding these aspects may help to determine how Tregs can be used in the treatment of autoimmune diseases.

AB - Foxp3+ T regulatory cell (Treg) subsets play a crucial role in the maintenance of immune homeostasis against self-antigens. The lack or dysfunction of these cells contributes to the pathogenesis and development of many autoimmune diseases. Therefore, manipulation of these cells may provide a novel therapeutic approach to treat autoimmune diseases. In this review, we provide current opinions concerning the classification, developmental, and functional characterization of Treg subsets. Particular emphasis will be focused on the therapeutic role of TGF-β-induced CD4M+ Foxp3 + cells (iTregs) in established autoimmune disease. Moreover, the similarity and diversity of iTregs and naturally occurring, thymus-derived CD4+ CD25+ Foxp3+ regulatory T cells (nTregs) will be discussed, including the finding that the pro-inflammatory cytokine IL-6 can convert nTregs to IL-17-producing cells, whereas iTregs induced by TGF-β are resistant to the effects of this cytokine. Understanding these aspects may help to determine how Tregs can be used in the treatment of autoimmune diseases.

UR - http://www.scopus.com/inward/record.url?scp=78751499888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78751499888&partnerID=8YFLogxK

U2 - 10.3109/08916931003782163

DO - 10.3109/08916931003782163

M3 - Review article

C2 - 20670119

AN - SCOPUS:78751499888

VL - 44

SP - 43

EP - 50

JO - Autoimmunity

JF - Autoimmunity

SN - 0891-6934

IS - 1

ER -